These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 989135

  • 1. Failure of vancomycin treatment in Staphylococcus aureus endocarditis. In vivo and in vitro observations.
    Gopal V, Bisno AL, Silverblatt FJ.
    JAMA; 1976 Oct 04; 236(14):1604-6. PubMed ID: 989135
    [Abstract] [Full Text] [Related]

  • 2. [Right endocarditis caused by Staphylococcus aureus in parenteral drug addicts: evaluation of a combined therapeutic scheme for 2 weeks versus conventional treatment].
    Espinosa FJ, Valdés M, Martín-Luengo F, Arribas JP, Albaladejo J, Pérez-Gracia A, García-Henarejos JA, Martínez-Madrid O, García-Alberola A.
    Enferm Infecc Microbiol Clin; 1993 May 04; 11(5):235-40. PubMed ID: 8324018
    [Abstract] [Full Text] [Related]

  • 3. Combination antibiotic therapy in staphylococcal endocarditis. The use of methicillin sodium-gentamicin sulfate therapy.
    Murray HW, Wigley FM, Mann JJ, Arthur RR.
    Arch Intern Med; 1976 Apr 04; 136(4):480-3. PubMed ID: 1267557
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of fosfomycin + vancomycin or gentamicin in experimental endocarditis due to methicillin-resistant Staphylococcus aureus (MRSA).
    Olay T, Vicente MV, Rodríguez A.
    J Chemother; 1989 Jul 04; 1(4 Suppl):391-2. PubMed ID: 16312454
    [No Abstract] [Full Text] [Related]

  • 5. Staphylococcus aureus endocarditis. Combined therapy with vancomycin and rifampin.
    Faville RJ, Zaske DE, Kaplan EL, Crossley K, Sabath LD, Quie PG.
    JAMA; 1978 Oct 27; 240(18):1963-5. PubMed ID: 249793
    [Abstract] [Full Text] [Related]

  • 6. Nafcillin-gentamicin synergism in experimental staphylococcal endocarditis.
    Sande MA, Courtney KB.
    J Lab Clin Med; 1976 Jul 27; 88(1):118-24. PubMed ID: 1047088
    [Abstract] [Full Text] [Related]

  • 7. Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic.
    Cosgrove SE, Vigliani GA, Fowler VG, Abrutyn E, Corey GR, Levine DP, Rupp ME, Chambers HF, Karchmer AW, Boucher HW.
    Clin Infect Dis; 2009 Mar 15; 48(6):713-21. PubMed ID: 19207079
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of vancomycin plus rifampin in experimental aortic-valve endocarditis due to methicillin-resistant Staphylococcus aureus: in vitro-in vivo correlations.
    Bayer AS, Lam K.
    J Infect Dis; 1985 Jan 15; 151(1):157-65. PubMed ID: 3965588
    [Abstract] [Full Text] [Related]

  • 9. Teicoplanin compared with vancomycin for treatment of experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis.
    Galetto DW, Boscia JA, Kobasa WD, Kaye D.
    J Infect Dis; 1986 Jul 15; 154(1):69-75. PubMed ID: 2940303
    [Abstract] [Full Text] [Related]

  • 10. [Teicoplanin versus cloxacillin, cloxacillin-gentamycin and vancomycin in the treatment of experimental endocarditis caused by methicillin-sensitive Staphylococcus aureus].
    Apellaniz G, Valdés M, Pérez R, Martín-Luengo F, García A, Soria F, Gómez J.
    Enferm Infecc Microbiol Clin; 1991 Apr 15; 9(4):208-10. PubMed ID: 1830757
    [Abstract] [Full Text] [Related]

  • 11. Therapy for experimental endocarditis due to Staphylococcus epidermidis.
    Kobasa WD, Kaye KL, Shapiro T, Kaye D.
    Rev Infect Dis; 1983 Apr 15; 5 Suppl 3():S533-7. PubMed ID: 6635444
    [Abstract] [Full Text] [Related]

  • 12. Failure of once-daily vancomycin for staphylococcal endocarditis.
    Marik PE.
    Pharmacotherapy; 1998 Apr 15; 18(3):650-2. PubMed ID: 9620118
    [Abstract] [Full Text] [Related]

  • 13. Ciprofloxacin therapy of experimental endocarditis caused by methicillin-susceptible or methicillin-resistant Staphylococcus aureus.
    Fernandez-Guerrero M, Rouse M, Henry N, Wilson W.
    Antimicrob Agents Chemother; 1988 May 15; 32(5):747-51. PubMed ID: 3164989
    [Abstract] [Full Text] [Related]

  • 14. Bactericidal activity of oxacillin and glycopeptides against Staphylococcus aureus in patients with endocarditis: looking for a relationship between tolerance and outcome.
    Pasticci MB, Moretti A, Stagni G, Ravasio V, Soavi L, Raglio A, Vailati F, Cardaccia A, Santucci A, Papili R, Sgrelli A, Pallotto C, Baldelli F.
    Ann Clin Microbiol Antimicrob; 2011 Jun 09; 10():26. PubMed ID: 21658248
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of ceftobiprole in a rabbit model of aortic valve endocarditis due to methicillin-resistant and vancomycin-intermediate Staphylococcus aureus.
    Chambers HF.
    Antimicrob Agents Chemother; 2005 Mar 09; 49(3):884-8. PubMed ID: 15728879
    [Abstract] [Full Text] [Related]

  • 16. Cost-Effectiveness of daptomycin versus vancomycin and gentamicin for patients with methicillin-resistant Staphylococcus aureus bacteremia and/or endocarditis.
    Bhavnani SM, Prakhya A, Hammel JP, Ambrose PG.
    Clin Infect Dis; 2009 Sep 01; 49(5):691-8. PubMed ID: 19635023
    [Abstract] [Full Text] [Related]

  • 17. Gentamicin may have no effect on mortality of staphylococcal prosthetic valve endocarditis.
    Ramos-Martínez A, Muñoz Serrano A, de Alarcón González A, Muñoz P, Fernández-Cruz A, Valerio M, Fariñas MC, Gutiérrez-Cuadra M, Miró JM, Ruiz-Morales J, Sousa-Regueiro D, Montejo JM, Gálvez-Acebal J, HidalgoTenorio C, Domínguez F, Spanish Collaboration on Endocarditis – Grupo de Apoyo al Manejo de la Endocarditis Infecciosa en España (GAMES).
    J Infect Chemother; 2018 Jul 01; 24(7):555-562. PubMed ID: 29628387
    [Abstract] [Full Text] [Related]

  • 18. Endocarditis due to streptomycin-susceptible Enterococcus faecalis with high-level gentamicin resistance.
    Spiegel CA, Huycke M.
    Arch Intern Med; 1989 Aug 01; 149(8):1873-5. PubMed ID: 2504123
    [Abstract] [Full Text] [Related]

  • 19. Antimicrobial therapy of experimental endocarditis caused by Staphylococcus aureus.
    Sande MA, Johnson ML.
    J Infect Dis; 1975 Apr 01; 131(4):367-75. PubMed ID: 1117194
    [Abstract] [Full Text] [Related]

  • 20. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus.
    Fowler VG, Boucher HW, Corey GR, Abrutyn E, Karchmer AW, Rupp ME, Levine DP, Chambers HF, Tally FP, Vigliani GA, Cabell CH, Link AS, DeMeyer I, Filler SG, Zervos M, Cook P, Parsonnet J, Bernstein JM, Price CS, Forrest GN, Fätkenheuer G, Gareca M, Rehm SJ, Brodt HR, Tice A, Cosgrove SE, S. aureus Endocarditis and Bacteremia Study Group.
    N Engl J Med; 2006 Aug 17; 355(7):653-65. PubMed ID: 16914701
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.